Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-11-22FDA Approved: DIGOXIN — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' generic digoxin product (DIGOXIN) under an original ANDA. Digoxin is used to treat heart failure and certa…
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: FAST PV and mGFR™ Technology in Congestive Heart Failure [NA]
Clinical trial update for FAST PV and mGFR technology in congestive heart failure has completed with results posted.
-
FDA approval · 2021-11-08FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for a generic metoprolol succinate product from Epic Pharma, LLC.
-
CLINICAL_TRIALS research · 2021-11-04Clinical Trial Update: A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD [NA]
Clinical trial update for a technology-assisted care transition intervention targeting veterans with congestive heart failure and chronic ob…
-
FDA approval · 2021-11-02FDA Approved: VALSARTAN — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original ANDA for valsartan, enabling generic manufacture and marketing of valsartan for its approved …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Effects of Echo-optimization of Left Ventricular Assist Devices on Functional Capacity (VAFRACT) [NA]
A completed clinical trial evaluating echo-optimization of left ventricular assist devices and its effect on functional capacity in heart fa…
-
FDA approval · 2021-10-27FDA Approved: VALSARTAN — Original Application (ScieGen Pharmaceuticals, INC.)
FDA approves the original application for VALSARTAN (Valsartan) from ScieGen Pharmaceuticals as a generic angiotensin II receptor blocker. I…
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Optimization of the Ambulatory Monitoring for Patients With Heart Failure by Tele-cardiology [NA]
Clinical trial update on ambulatory monitoring for chronic heart failure using tele-cardiology; study completed with results posted in 2021.
-
FDA approval · 2021-10-25FDA Approved: EPLERENONE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approves Westminster Pharmaceuticals' original ANDA for EPLERENONE (generic eplerenone), providing a generic option for hypertension and…
-
CLINICAL_TRIALS trial_result · 2021-10-22Clinical Trial Update: Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing [Phase 4]
Phase 4 clinical trial comparing pre-dosing versus concurrent dosing of metolazone for diuretic effect in fluid overload and acute heart fai…
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF) [Phase 3]
Phase 3 trial update for Ferinject in patients with iron deficiency and chronic heart failure.
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Acupuncture for Individuals With Stable Angina [NA]
A terminated clinical trial evaluating acupuncture for individuals with stable angina has posted results in 2021.
-
FDA approval · 2021-10-05FDA Approved: VALSARTAN — Original Application (Dr. Reddy's Laboratories Limited)
FDA approves the original application for valsartan from Dr. Reddy's Laboratories Limited, granting approval for the generic product.
-
FDA approval · 2021-10-01FDA Approved: RAMIPRIL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Ramipril from Rising Pharma Holdings, Inc., enabling the continued manufacture and distribut…
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis [Phase 4]
Phase 4 clinical trial assessing the effect of influenza vaccination on future cardiovascular prognosis after myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure [Phase 1, Phase 2]
A crossover pharmacokinetic and bioavailability study comparing subcutaneous versus intravenous administration of a novel furosemide regimen…
-
CLINICAL_TRIALS trial_result · 2021-09-17Clinical Trial Update: Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C [NA]
A completed clinical trial evaluating the OPTIMIZER System for safety and efficacy in moderate-to-severe heart failure (NYHA Class III/IV). …
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure [Phase 4]
A Phase 4 clinical trial update on an influenza vaccine aimed at reducing cardiovascular events in patients with heart failure and prior myo…
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Sodium Thiosulfate to Preserve Cardiac Function in STEMI [Phase 2]
Phase 2 clinical trial evaluating sodium thiosulfate to preserve cardiac function after a myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake [Phase 3]
Phase 3 safety trial of OPC-61815 Injection in patients with congestive heart failure who cannot take oral medication has completed with res…
-
CLINICAL_TRIALS trial_result · 2021-08-26Clinical Trial Update: Baroreflex Activation Therapy in Heart Failure [NA]
Completed clinical trial update for Baroreflex Activation Therapy in heart failure; results posted in 2021.
-
FDA approval · 2021-08-20FDA Approved: METOLAZONE — Original Application (Advagen Pharma Limited)
FDA approved Advagen Pharma Limited's Original Application for METOLAZONE, granting approval of a generic diuretic.
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction [Phase 4]
A Phase 4 trial investigating the effect of levosimendan on left ventricular systolic function and heart failure after PCI in patients with …
-
FDA approval · 2021-08-17FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for lisinopril from Camber Pharmaceuticals, Inc., for the generic product.
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: Effect of Intravenous FerRic carbOxymaltose oN Reverse Remodeling Following Cardiac Resynchronization Therapy [Phase 4]
A Phase 4 clinical trial evaluating the effect of intravenous ferric carboxymaltose on reverse remodeling after cardiac resynchronization th…